Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Axys Advanced Technologies Inc.

Division of Quest Diagnostics Inc.

Latest From Axys Advanced Technologies Inc.

Elitra Pharmaceuticals Inc.

Elitra Pharmaceuticals Inc. has developed a rapid and systematic method to sequence the entire genome of microbial organisms. It will identify the genes essential to the organisms' survival and use its proprietary bioinformatics platform to prioritize and validate gene targets. Alone and with partners, it will develop and commercialize novel antibiotic and antifungal drugs to inhibit the growth of major microbial pathogens, many of which are becoming resistant to current therapeutics.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Quest Diagnostics Inc.
  • Senior Management
  • Robert A Reed, PhD., Pres.
    Nathan Collins, PhD., Dir., Oper.
    Leslie A Stolz, PhD., Dir., Bus. Dev.
  • Contact Info
  • Axys Advanced Technologies Inc.
    385 Oyster Point Blvd.
    Ste. 1
    South San Francisco, CA 94080